factor

(redirected from migration inhibitory factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
Jung, "Macrophage migration inhibitory factor is elevated in obese adolescents," Archives of Physiology and Biochemistry, vol.
Piccoli et al., "Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia," European Journal of Obstetrics Gynecology and Reproductive Biology, vol.
Calandra, "Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1," European Journal of Immunology, vol.
Navarro-Hernandez et al., "Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course," Rheumatology International, vol.
Hirano et al., "High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus," Atherosclerosis, vol.
Caption: FIGURE 1: The relationship between different pathophysiological processes implicated in AP and susceptibility genes is concluded as follows: PRSS1: cationic trypsinogen; SPINK1: serine protease inhibitor Kazal type 1; CTRC: chymotrypsin C; ACE: angiotensin- converting enzyme; MIF: migration inhibitory factor; iNOS: inducible nitric oxide synthase; COX-2: cyclooxygenases 2; MYO9B: myosin IXB; TLRs: toll-like receptors; MCP-1: monocyte chemoattractant protein-1; HBDs: human [beta]-defensin 2; MBL2: mannose-binding lectin 2; TNF-[alpha]: tumor necrosis factor-[alpha]; IL-10: interleukin 10; TLR4: toll-like receptor 4.
Illmer et al., "The expression of macrophage migration inhibitory factor 1a (MIF 1a) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability," Atherosclerosis, vol.
* The report provides a snapshot of the global therapeutic landscape for Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.3.2.1)
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.
The serum concentrations of IL-6, IL-8, IL-10, and macrophage migration inhibitory factor (MIF) were determined in the Physiology Laboratory at a Biomedical Science Building in a Level I academic medical center.
(11.) Rahman SH, Menon KV, Holmfield JH, McMahon MJ, Guillou JP: Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164-170, doi: 10.1038/72262.

Full browser ?